Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Seres Therapeutics, Inc.Listing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Kaleido Biosciences, Inc.Listing on record | Buy | $824.2K | conv 20First in 12mo | SEC | |
Kaleido Biosciences, Inc.Listing on record | Buy | $824.2K | conv 23First in 12mo | SEC | |
Kaleido Biosciences, Inc.Listing on record | Buy | $824.2K | conv 19First in 12mo | SEC |